H.I.G. Capital (“H.I.G.”), a leading global alternative asset investment firm with over $49 billion of equity capital under management, announced that Stephan Madsen has...
The U.S. Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes, as an...
Following the launch of QUVIVIQ™ (daridorexant) CIV on May 2, Idorsia Pharmaceuticals, U.S. Inc. announced that the first wave of patients has been prescribed...
Diadem SpA announced publication of the results of a clinical validation study of its AlzoSure Predict prognostic blood test for Alzheimer's disease (AD). The...
German life science biotech firm, LenioBio GmbH, announced the generation of a novel plant glycan knockout cell line that will increase the versatility and...
